Top Italian Scientists join the discussion of AI and Machine Learning presented by the Sbarro Health Research Organization (SHRO) in collaboration with the National Italian American Foundation (NIA) this weekend at the annual NIAF convention and gala.
Models built on machine learning in health care can be victims of their own success, according to researchers at the Icahn School of Medicine and the University of Michigan.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Corewell Health™ has become the first and only health system in Michigan to implant a device intended to improve upper body mobility in patients who have experienced a debilitating stroke.
Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
A device has been created that could carry out Clinical Breast Examinations (CBE).
A tool for evaluating the overall cost of a surgical procedure, called a scorecard, helps reduce costs of surgical procedures between 5% and 20% without adversely affecting clinical outcomes.
A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation, a large new international study suggests.
Mount Sinai investigators have developed a new approach for treating invasive bladder cancer without the need for surgical removal of the bladder, according to a study published in Nature Medicine in September.
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues.
Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests.
People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.
Orange, Calif. — The University of California, Irvine has launched an initiative to address the toll diabetes takes on Orange County’s Latinx community and ensure greater well-being for a population that is disproportionately affected by the disease.
Researchers are working to improve outcomes for Black women with breast cancer – including through increased participation in clinical trials, which helps find better ways to prevent, diagnose and treat cancer.
To become part of the standard of care in doctors’ offices and hospitals and to be covered by health insurance, new medications and procedures go through a rigorous testing process.
Physician-scientists from the Department of Radiation Oncology at Cedars-Sinai Cancer will present the latest research breakthroughs and discuss advances in clinical care at the American Society for Radiation Oncology (ASTRO) annual meeting Oct. 1-4, 2023, in San Diego.
RUDN University chemists and colleagues from China built several machine learning models and discovered a group of potential drugs that inhibit the enzyme responsible for uncontrolled cell division.
A new drug encourages weight loss and increases endurance by making the body act like it is exercising.
When children undergo cancer treatment, they may be offered the chance to participate in a clinical trial. Clinical trials can provide access to new, groundbreaking therapies in a safe and controlled environment.
The Trauma and Transfusion Medicine Research Center (TTMRC) in the Department of Surgery at the University of Pittsburgh School of Medicine is launching a $34 million, federally funded clinical trial to simultaneously test multiple interventions for life-threatening bleeding in at least 1,000 traumatically injured children across 20 U.S. pediatric trauma centers.
Researchers will need fewer mice to study lung infections thanks to improvements in dosing methods, according to a new study from the University of California San Francisco (UCSF).
Women aged 18 to 44 living in states that outlaw Sunday liquor sales or driving with a blood alcohol concentration greater than .08 drink less than their counterparts in other states, according to a new study recently published in Alcohol: Clinical and Experimental Research.
The study led by King’s College London, compared the safety and efficacy of ciclosporin with methotrexate in children and young people with this debilitating skin condition. They also examined whether the severity of the disease changed or returned after treatment ended.
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
UCI researchers have found that a simple sugar, N-acetylglucosamine, reduces multiple inflammation and neurodegeneration markers in people who suffer from multiple sclerosis (MS). In addition, they also found this dietary supplement improved neurological function in 30% of patients.
A five-year, $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.
Phase I clinical trials provide an opportunity for cancer patients to access novel drugs or combinations of drugs for those in need of new options. Experts from Hackensack Meridian Hackensack University Medical Center’s John Theurer Cancer Center have now established a satellite phase I clinical trial program at Hackensack Meridian Jersey Shore University Medical Center.
The American Society for Radiation Oncology (ASTRO) announced today the 10 studies to be highlighted in the 2023 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held October 2 and 3 at the San Diego Convention Center and via live webcast.
A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.
As part of its partnership with the Patient-Centered Outcomes Research Institute (PCORI), Medical Care has published its first PCORI-sponsored article collection, which provides specific information about the costs that healthcare systems can expect to incur in promoting the uptake of specific evidence-based programs.
Researchers from UChicago will lead the next phase of the Illinois Precision Medicine Consortium (IPMC)'s participation in the National Institutes of Health's All of Us Research Program.
Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.Reporting on wildfire smoke? Fred Hutch clinicians and researchers are available to their expertise.
A new Columbia Nursing study analyzes the performance of ADscreen, a computerized speech processing algorithm that is being developed to support clinicians in detecting and monitoring the progression of Alzheimer's disease and related dementias early.
Wits Bone Research Lab the only unit of its kind to show that a bone-forming protein can block growth of human squamous cell
The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
In June 2021, Bob McCarrick and his wife Stacey headed out to Los Angeles to enroll in the MIRAGE trial and start radiation therapy.
Results from a large-scale clinical trial could increase usage of high resolution imaging for guiding interventional coronary procedures
This method produced enrollment rates many times higher than is typically seen for patient portal based recruitment – and unexpectedly increased racial and ethnic participation as well. So it could be a promising new tool to improve research recruitment and diversity in biomedical research.
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent studies from Oregon State University found.
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a functional role for KRAS mutations in pancreatic cancer and rapidly translated these findings into a novel therapeutic approach combining a KRAS G12D inhibitor with immune checkpoint inhibitors for early- and late-stage KRAS G12D-mutant pancreatic cancer.
The Speech Accessibility Project is almost halfway through its first phase of gathering voice recordings from people with Parkinson’s. Project participant and Parkinson's advocate Ethan Henderson can comment.
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
